Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets.
Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW. · 2021
Read Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. by Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7910446.txt.
Description
Wang and co-authors present a review of arachidonic acid metabolism and its promise as a drug target. Arachidonic acid sits in cell membranes until an enzyme frees it. Other enzymes then turn it into a wide family of active signals. Those signals shape heart health, cancer growth, and diseases such as asthma and arthritis.
Three main enzyme routes do the conversion work. Their products include prostanoids, leukotrienes, and epoxyeicosatrienoic acids. Some products drive harm, while others protect tissue. The review sets out how each route works in health and disease. It gives special weight to heart disease and cancer. Early clinical studies that target these routes are also covered. The authors argue the pathways offer rich ground for new preventive and treatment drugs.
Catalog record
| CREATOR | Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 138 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |